|
tomaymycin |
|
CHEBI:157681 |
|
A pyrrolobenzodiazepine that is (11aS)-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine which is substituted at positions 2,5,7,8 and 11R by ethylidene, oxo, methoxy, hydroxy and methoxy groups, respectively. It is a natural product of Streptomyces achromogenes that binds covalently with guanine in the minor groove of DNA. It is an antitumoral compound which is active in ovarian, plasmacytoma, and leukemia cancer cell lines at nanomolar concentrations. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Martin Larralde
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C16H20N2O4/c1-4-9-5-12-15(22-3)17-11-7-13(19)14(21-2)6-10(11)16(20)18(12)8-9/h4,6-7,12,15,17,19H,5,8H2,1-3H3/t12-,15+/m0/s1 |
UQVNRKBFAXNOGA-SWLSCSKDSA-N |
[H]C(C)=C1CN2C(=O)C3=CC(OC)=C(O)C=C3N[C@H](OC)[C@]2([H])C1 |
|
Streptomyces achromogenes
(NCBI:txid67255)
|
See:
PubMed
|
antibacterial agent
A substance (or active part thereof) that kills or slows the growth of bacteria.
alkylating agent
Highly reactive chemical that introduces alkyl radicals into biologically active molecules and thereby prevents their proper functioning. It could be used as an antineoplastic agent, but it might be very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. It could also be used as a component of poison gases.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(11R,11aS)-2-ethylidene-8-hydroxy-7,11-dimethoxy-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
|
35050-55-6
|
CAS Registry Number
|
ChemIDplus
|
1501225
|
PubMed citation
|
Europe PMC
|
18925745
|
PubMed citation
|
Europe PMC
|
19270147
|
PubMed citation
|
SUBMITTER
|
21809870
|
PubMed citation
|
SUBMITTER
|
28890318
|
PubMed citation
|
Europe PMC
|
29916519
|
PubMed citation
|
SUBMITTER
|
581831
|
PubMed citation
|
SUBMITTER
|
7932537
|
PubMed citation
|
Europe PMC
|
8785351
|
PubMed citation
|
SUBMITTER
|
9054552
|
PubMed citation
|
Europe PMC
|
|